ANA
CONEJO GARCÍA
CATEDRÁTICA DE UNIVERSIDAD
Publicaciones (64) Publicaciones de ANA CONEJO GARCÍA
2023
-
N-aryltetrahydroisoquinoline derivatives as HA-CD44 interaction inhibitors: Design, synthesis, computational studies, and antitumor effect
European Journal of Medicinal Chemistry, Vol. 258
-
Preclinical evaluation of bozepinib in bladder cancer cell lines: modulation of the NPP1 enzyme
Purinergic Signalling
2022
-
Selective Anticancer Therapy Based on a HA-CD44 Interaction Inhibitor Loaded on Polymeric Nanoparticles
Pharmaceutics, Vol. 14, Núm. 4
2021
-
Design, synthesis, HER2 inhibition and anticancer evaluation of new substituted 1,5-dihydro-4,1-benzoxazepines
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 36, Núm. 1, pp. 1553-1563
-
Development of bozepinib-loaded nanocapsules for nose-to-brain delivery: Preclinical evaluation in glioblastoma
Nanomedicine, Vol. 16, Núm. 23, pp. 2095-2115
-
New insights into cytotoxic mechanisms of bozepinib against glioblastoma
European Journal of Pharmaceutical Sciences, Vol. 162
-
Recent advances in the design of choline kinase α inhibitors and the molecular basis of their inhibition
Medicinal Research Reviews, Vol. 41, Núm. 2, pp. 902-927
2020
-
Bozepinib: A Promising Selective Derivative Targeting Breast Cancer Stem Cells
Translational Research in Cancer (IntechOpen)
2018
-
Enhancement of tumor cell death by combining gef gene mediated therapy and new 1,4-benzoxazepin-2,6-dichloropurine derivatives in breast cancer cells
Frontiers in Pharmacology, Vol. 9, Núm. JUL
2017
-
1-(Benzenesulfonyl)-1,5-dihydro-4,1-benzoxazepine as a new scaffold for the design of antitumor compounds
Future Medicinal Chemistry, Vol. 9, Núm. 11, pp. 1129-1140
-
Antitumoral activity of 1,2-diaminocyclohexane derivatives in breast, colon and skin human cancer cells
Future Medicinal Chemistry, Vol. 9, Núm. 3, pp. 293-302
-
Choline kinase inhibition and docking studies of a series of 6-(benzylthio)-9H-purin-9-yl-pyridinium derivatives
Medicinal Chemistry Research, Vol. 26, Núm. 11, pp. 2809-2815
-
Lysophosphatidylcholine Regulates Sexual Stage Differentiation in the Human Malaria Parasite Plasmodium falciparum
Cell, Vol. 171, Núm. 7, pp. 1532-1544.e15
-
Synthesis of 1,4-benzoxathiin-9H-purine derivatives as antiproliferative agents
Targets in Heterocyclic Systems, Vol. 21, pp. 372-388
2016
-
1H and 13C NMR spectral data of p-nitrobenzenesulfonamides and dansylsulfonamides derived from N-alkylated o-(Purinemethyl)anilines
Magnetic Resonance in Chemistry
-
Plasmodium falciparum Choline Kinase Inhibition Leads to a Major Decrease in Phosphatidylethanolamine Causing Parasite Death
Scientific Reports, Vol. 6
2015
-
P-Nitrobenzenesulfonamides and their fluorescent dansylsulfonamides derived from N-alkylated o-(purine-methyl)anilines as novel antitumour agents
RSC Advances, Vol. 5, Núm. 93, pp. 76615-76619
2014
-
Anti-proliferative activity of 2,6-dichloro-9- or 7-(ethoxycarbonylmethyl)- 9H- or 7H-purines against several human solid tumour cell lines
European Journal of Medicinal Chemistry, Vol. 76, pp. 118-124
-
Discovery of a new binding site on human choline kinase α1: Design, synthesis, crystallographic studies, and biological evaluation of asymmetrical bispyridinium derivatives
Journal of Medicinal Chemistry, Vol. 57, Núm. 2, pp. 507-515
-
HER2-signaling pathway, JNK and ERKs kinases, and cancer stem-like cells are targets of Bozepinib small compound
Oncotarget, Vol. 5, Núm. 11, pp. 3590-3606